Nathan Pennell
Cleveland Clinic Foundation

Last Updated On 1/17/2024 11:29:07 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Lilly
Recipient: You
Company: Merck
Recipient: You
Company: Genentech
Recipient: You
Company: Pfizer
Recipient: You
Company: Janssen Oncology
Recipient: You
Company: Sanofi/Regeneron
Recipient: You
Company: ResistanceBio
Recipient: You
Company: Takeda
Recipient: You
Company: Novartis
Recipient: You
Company: Vial CRO
Recipient: You
Company: Bayer
Recipient: You
Company: Anheart Therapeutics
Recipient: You
Company: Summit Therapeutics
Recipient: You
Company: Iovance Biotherapeutics
Recipient: You
Company: Picture Health
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: AstraZeneca
Recipient: Your Institution
Company: Merck
Recipient: Your Institution
Company: Loxo
Recipient: Your Institution
Company: Spectrum Pharmaceuticals
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Mirati Therapeutics
Recipient: Your Institution
Company: Sanofi
Recipient: Your Institution
Company: Anheart Therapeutics
Recipient: Your Institution
Company: Navire
Recipient: Your Institution
Company: Summit pharmaceuticals
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
Open Payments URL: https://openpaymentsdata.cms.gov/physician/204570/summary